Evidence based practices related to the

management of neonatal respiratory distress

syndrome

Presented by ; Mahmoud Al zoubi .RN

Background
Neonatal RDS happen in which lungs not fully
developed in neonate especially premature
. babies related to surfactant deficiency
RDS also Known as hyaline membrane disorder,
that showed a signs of : tachypnoea, nasal
.)faring , grunting ,blue color..ext
)NHS,2021(
 Background; Significance
Respiratory distress syndrome is most common
.neonatal death in preterm infant

RDS accounted for 2.3 % of all infant death in US

. 2013
 Purpose
To review up to date management of respiratory
distress syndrome, that will enhance the
. quality of care in management
 Methodology
Literature searched was performed in Google
scholarly , Pubmed , Elm , data based for free
full text articles
 Result
Prenatal care : single dose of corticosteroid
recommended of preterm before 34 weeks
: Delivery room stabilization
 Urgent airway opening in babies with hypoxia
 In spontaneous breath baby : stabilize with CPAP (6cm H20)
 In infant < 32 weeks keep Spo2 80% or more
 Oxygen should be used as following :

Fio2 Weeks Age in

0.30 28<
0.21-0.30 28-31
0.21-0.30 32

 Plastic wrapped and use radiant warmer < 28 weeks

 ; Result
Intubation :should be used for baby not
responding to positive pressure ventilation
: Surfactant administration
 babies should be given rescue surfactant who are
worsening and need fio2 > 0.30.
 Recommended dose initially 200mg/kg.
 LISA ( Less invasive surfactant administration ) it’s the
preferred method.
 ; Result
Non invasive respiratory support :
preterm should be managed without
( MV) mechnical ventilation ,CPAP has been
used for over 40 years effectives in reducing
the intubation
: Conclusions and recommendation
Most preterm with RDS can be treated with non
invasive methods, in addition of other
.supportive care

Follow updated protocol will affect the quality of

.care and decrease the incidence of death